Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.49 |
| ▸ | MEN1 | O00255 | 5/20 | 0.49 |
| ▸ | PKM | P14618 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.42 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.41 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1713198 | 0.84 | SYK (0.41) | ALDH1A1KMT2AMEN1MAPTGAA | |
| SCHEMBL4848737 | 0.82 | ALDH1A1 (0.66) | ALDH1A1KMT2AMEN1PKMMAPT | |
| SCHEMBL56881 | 0.80 | ALDH1A1 (0.59) | ALDH1A1KMT2AMEN1PKMMAPT | |
| SCHEMBL6574005 | 0.71 | HTT (0.58) | ALDH1A1KMT2AMEN1PKMMAPT | |
| SCHEMBL18158082 | 0.71 | GRIN2D (0.38) | ALDH1A1LMNA | |
| SCHEMBL30354912 | 0.71 | ALDH1A1 (0.59) | ALDH1A1KMT2AMEN1PKMMAPT | |
| SCHEMBL6017266 | 0.71 | ALDH1A1 (0.59) | ALDH1A1KMT2AMEN1PKMMAPT | |
| SCHEMBL18158015 | 0.70 | SCN8A (0.41) | ALDH1A1LMNA | |
| SCHEMBL29886060 | 0.69 | KCNMA1 (0.66) | ALDH1A1KMT2AMEN1PKMMAPT | |
| SCHEMBL16592416 | 0.69 | KCNMA1 (0.66) | ALDH1A1KMT2AMEN1PKMMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8129137-B2 | Two-photon probe for real-time monitoring of intracellular free zinc ions, method for preparing the probe and method for real-time monitoring of intracellular free zinc ions using the probe | KOREA UNIVERSITY INDUSTRIAL & ACADEMIC COLLABORATION FOUNDATION (KR) | 2012-03-06 | — | — | US | disclosed |
| US-20090286275-A1 | Two-photon probe for real-time monitoring of intracellular free zinc ions, method for preparing the probe and method for real-time monitoring of intracellular free zinc ions using the probe | SFC CO., LTD. (KR) | 2009-11-19 | — | — | US | disclosed |
| EP-2119456-A1 | Two-photon probe for real-time monitoring of intracellular free zinc ions, method for preparing the probe and method for real-time monitoring of intracellular free zinc ions using the probe | Korea University Industrial & Academic Collaboration Foundation (KR) | 2009-11-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286275-A1 | Two-photon probe for real-time monitoring of intracellular free zinc ions, method for preparing the probe and method for real-time monitoring of intracellular free zinc ions using the probe | SLC39A3, SLC30A7, SLC39A7 | ALDH1A1 3815/4885KMT2A 3594/4885MEN1 1569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.